HEDGEHOG: Hierarchical Evaluation of Drug Generators Through Rigorous Filtration
- URL: http://arxiv.org/abs/2607.13155v1
- Date: Tue, 14 Jul 2026 18:05:28 GMT
- Title: HEDGEHOG: Hierarchical Evaluation of Drug Generators Through Rigorous Filtration
- Abstract summary: Generative molecular models can support early drug discovery by proposing new candidate compounds de novo.<n>We introduce HEDGEHOG, a unified six-stage filtration benchmark inspired by industrial hit identification.<n>Across 230,000 generated molecules, only 0.65% of initial molecules survive all stages.
- Score: 32.613477872461324
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Generative molecular models can support early drug discovery by proposing new candidate compounds de novo. In practice, useful candidates must balance target-relevant activity, synthetic accessibility, physicochemical properties, and other multiparameter design constraints. However, metrics commonly used to evaluate molecular generators only weakly reflect whether the generated compounds are medicinally plausible and suitable for downstream computation. This can produce false positives in model evaluation, incorrect assumptions, and inefficient use of computational resources. We introduce HEDGEHOG, a unified six-stage filtration benchmark that is inspired by industrial hit identification workflows: (i) preprocessing; (ii) physicochemical descriptor screening; (iii) structural alerts and graph-sanity checks; (iv) synthesis feasibility; (v) docking and binding affinity estimation; and (vi) three-dimensional pose and interaction checks. We evaluate 23 molecular generators across three model classes under a standardized protocol. Across 230,000 generated molecules, only 0.65% of initial molecules survive all stages. Our results expose a central limitation of current molecular generators: molecules that appear acceptable under isolated criteria rarely satisfy medicinal chemistry, synthesis, docking, and 3D pose filters simultaneously.
Related papers
- Zatom-1: A Multimodal Flow Foundation Model for 3D Molecules and Materials [51.342983349686556]
General-purpose 3D chemical modeling encompasses molecules and materials, requiring both generative and predictive capabilities.<n>We introduce Zatom-1, the first end-to-end, fully open-source foundation model that unifies generative and predictive learning of 3D molecules and materials.
arXiv Detail & Related papers (2026-02-24T20:52:39Z) - From In Silico to In Vitro: Evaluating Molecule Generative Models for Hit Generation [1.7744342894757368]
We investigate whether generative models can replace one step of the pipeline: hit-like molecule generation.<n>Specifically, we investigate if such models can be trained to generate hit-like molecules, enabling direct incorporation into, or even substitution of, traditional hit identification.<n>Our results show that these models can generate valid, diverse, and biologically relevant compounds across multiple targets.
arXiv Detail & Related papers (2025-12-26T14:02:59Z) - Conditional Synthesis of 3D Molecules with Time Correction Sampler [58.0834973489875]
Time-Aware Conditional Synthesis (TACS) is a novel approach to conditional generation on diffusion models.
It integrates adaptively controlled plug-and-play "online" guidance into a diffusion model, driving samples toward the desired properties.
arXiv Detail & Related papers (2024-11-01T12:59:25Z) - Molecule Design by Latent Prompt Transformer [76.2112075557233]
This work explores the challenging problem of molecule design by framing it as a conditional generative modeling task.
We propose a novel generative model comprising three components: (1) a latent vector with a learnable prior distribution; (2) a molecule generation model based on a causal Transformer, which uses the latent vector as a prompt; and (3) a property prediction model that predicts a molecule's target properties and/or constraint values using the latent prompt.
arXiv Detail & Related papers (2024-02-27T03:33:23Z) - Target Specific De Novo Design of Drug Candidate Molecules with Graph Transformer-based Generative Adversarial Networks [0.0]
We propose an end to end generative system, DrugGEN, for the de novo design of drug candidate molecules.<n>The system is trained using a large dataset of drug like compounds and target specific bioactive molecules.<n>It is possible to easily train models for other druggable proteins, given a dataset of experimentally known bioactive molecules.
arXiv Detail & Related papers (2023-02-15T18:59:27Z) - Retrieval-based Controllable Molecule Generation [63.44583084888342]
We propose a new retrieval-based framework for controllable molecule generation.
We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria.
Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
arXiv Detail & Related papers (2022-08-23T17:01:16Z) - A biologically-inspired evaluation of molecular generative machine
learning [17.623886600638716]
A novel biologically-inspired benchmark for the evaluation of molecular generative models is proposed.
We propose a recreation metric, apply drug-target affinity prediction and molecular docking as complementary techniques for the evaluation of generative outputs.
arXiv Detail & Related papers (2022-08-20T11:01:10Z) - Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE)
Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor.
We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
arXiv Detail & Related papers (2022-06-06T06:17:11Z) - MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties.
We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
arXiv Detail & Related papers (2020-10-05T20:18:42Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.